Abstract: Methodologies are presented for assessing the feasibility of parameter estimation in nonlinear ordinary di erential equation (ODE) models. These methods are applied to a recent model for hepatitis C viral dynamics. Subset selection is performed on the model parameters, and maximum likelihood estimation is conducted using available data from the literature.
Introduction . Background
The rapid increase in availability of biomedical data has assisted the development of mathematical models to understand the behavior of many human diseases. In particular, nonlinear ODEs have been used to model intra-host dynamics of viral infections such as hepatitis C virus (HCV) and HIV [ , , , ] . The use of such models continues to provide insights into disease pathogenesis as well as optimal treatment strategies.
In general, the term forward problem refers to the process of computing a model's output given a specific set of parameters. In the context of ODEs, the forward problem of finding a solution to the model equations has been well-studied, and a variety of analytical and numerical techniques are available. However, when modeling biological phenomena such as viral dynamics, one must typically estimate parameter values from the experimentally measured output variables. This process of inferring model parameters is known as an inverse problem, which is often formulated in terms of least squares or maximum likelihood. Setting aside the di culties of the resulting numerical optimization, the solution of inverse problems is still highly nontrivial. The structure of the model, the quantity and quality of the data, and the timing of the experimental measurements can make parameters impossible to estimate accurately. To avoid making spurious inferences, one should address the feasibility of the problem prior to conducting parameter estimation. Parameters which cannot be accurately estimated should be fixed in the model to reasonable values.
In this paper, we study parameter estimation in a model for HCV using techniques from sensitivity and identifiability analysis. Sensitivity analysis is used to determine which model parameters most influence the output. The natural connection to inverse problems is that parameters which are not sensitive may be dicult to estimate. Identifiability analysis, on the other hand, addresses the question of whether solutions to the inverse problem are unique, i.e., whether di erent sets of parameters can provide equally optimal fits. Literature on identifiability of nonlinear ODEs used to model viral dynamics was recently reviewed by Miao, Xia, Perelson and Wu [ ]. Most of this work is in the context of HIV, however, and identifiability of hepatitis C models is less examined [ , ] . Baker, Bocharov, Paul and Rihan [ ] also give a general discussion of sensitivity, identifiability, and parameter selection in similar models without focusing on any particular modeling setting. This paper addresses a need for the combined study of the sensitivity and identifiability of HCV model parameters.
. Modeling
The first mathematical model of hepatitis C viral dynamics was formulated in by Neumann, Lam, Dahari, Gretch, Wiley, Layden and Perelson to study the antiviral e ects of interferon-α (IFN) [ ]. The model is given by
where the state variables T and I denote concentrations of healthy and infected hepatocytes, and V represents the concentration of virions in the liver fluid. At the time, it was unknown whether IFN acted by inhibiting infection of healthy cells or by reducing virion production in infected cells. In the model, these two mechanisms correspond to η > and ϵ > , respectively. A major contribution of [ ] was determining that interferon acts through the ϵ mechanism rather than the η mechanism, i.e., that IFN acts by inhibiting the production of virions. Since these initial modeling e orts, the standard of care for HCV has evolved to include IFN as well as the antiviral ribavirin, which acts by rendering some virions noninfectious [ ]. To study the response of hepatitis C to this combined treatment, Snoeck et al. [ ] proposed several additions to the original Neumann model. This revised model is as follows:
Note that V I denotes the concentration of infectious virions, and V NI represents the concentration of noninfectious virions. Also note the addition of terms with coe cient r that correspond to the liver's regenerative properties. The dynamics of this system after the end of treatment are of interest, so Snoeck et al. [ ] include exponential decay of the drug e cacies ϵ and ρ, which correspond to IFN and ribavirin. In other words, we haveε (t) = ϵe
where t end marks the end of treatment, and
One final feature of the model is that virion production is "switched o " -that is, terms involving p are eliminated -while the concentration of infected cells is lower than per . × mL, as this implies there is less than one such cell in the entire liver. 
is the only function of the state variables typically observed in a clinical setting. Additionally, the viral load is measurable only to a minimum value of around international units/mL [ ]. Thus, the available viral load data are left-censored, as shown by Figure . As we will discuss, the presence of censored data negatively impacts identifiability and also complicates maximum likelihood parameter estimation.
Methods . Parameter estimation
A common method for conducting parameter estimation in ODE models is minimization of an ordinary least squares cost function [ ]. Suppose q is a vector containing the estimated parameters in the Snoeck model. We define a cost function
where V measured (t j ) is the experimentally measured viral load at the jth time point, and V model is the model output. The parameter estimation problem is then to compute the unique minimizer of J, if it exists. Note that uniqueness of the minimizing parameter vector is an issue addressed by identifiability analysis.
The initial conditions for our system are not known a priori and are di cult to measure in a clinical setting. Thus, we follow the methodology of Ransley [ ], who also worked with the Snoeck model, and take initial conditions equal to the infected steady state of the model, which depends on the parameters. Assuming the data are uncensored and produced by the model with additive and independent Gaussian noise, the ordinary least squares estimate is also the maximum likelihood estimate. However, in our case there is censoring in the data, and least squares does not su ce as a statistically rigorous methodology. Instead we compute maximum likelihood parameter estimates using an expectation maximization (EM) algorithm [ ]. Details regarding the use of this algorithm with ODE models can be found in [ , ] .
To accompany the parameter estimates, we compute the usual asymptotic confidence intervals [ ]. Suppose we are estimating a parameter vector q ∈ ℝ M with the least squares solutionq . Assuming Gaussian errors with variance σ and a large sample size N, the sampling variance of the least squares estimateq j is
is the sensitivity matrix (described below). Since s j is unknown, we use the estimateŝ j obtained by plugging inq andσ for the true values. We use a standard estimate,
for the variance parameter. An approximate % confidence interval for q j is thenq j ± τ
denotes the . quantile of a Student's t-distribution with N − M degrees of freedom. Note that the theory for these confidence intervals does not hold in the censored data setting; thus, we only give confidence intervals when the viral load data is well above the censoring level.
. Sensitivity analysis
When conducting parameter estimation, the relation between parameters and model output is of obvious importance and can be studied using techniques from sensitivity analysis. In particular, we compute sensitivity functions which quantify the e ects of small perturbations in the parameters. These functions are merely partial derivatives of state or output variables with respect to parameters. For example, in our case ∂V ∂p (t; q * ) is the sensitivity of viral load to the parameter p, evaluated at q * . Because the sensitivity functions depend on the nominal value q * , they are inherently local. Additionally, if at time t the viral load falls below the censoring level, infinitesimal perturbations to the parameters will have no e ect on the observed viral load. In this case all sensitivities ∂V ∂q j (t; q * ) are zero.
We compute sensitivity functions numerically since analytical solutions to the Snoeck model are not available. For ease of notation, let
T and let y = V I + V NI be the output. Our model is given by As an extreme case, suppose the model output is not sensitive at all to a certain parameter and ∂y ∂q j = . The parameter q j will be impossible to estimate because it has no influence on the model output. In practice, one compares the sensitivities of model parameters relative to one another. It is useful, then, to scale the output sensitivities and compute dimensionless sensitivity coe cients,
Parameters with drastically lower sensitivities are less likely to be identifiable from data. Local sensitivity analysis can be inadequate if the uncertainty in the parameter values is high. Thus, a global sensitivity analysis may be required. If the patient-specific parameters are assumed to follow some probability distribution F(q) on the population level, one can in principle compute expected values of the local sensitivity coe cients:
In practice the numerical integration may be intractable due to the high dimensional space of parameters Q. Hence, we use a Monte Carlo approximation. We generate a sequence of independent parameter values {q k } B k= from the distribution F(q) and approximate the expected value with a sample mean:
Since each Monte Carlo estimate is just a sample mean, we are guaranteed convergence by the law of large numbers and can form confidence intervals based on the central limit theorem.
For the global sensitivity analysis in this work, we take the patient-specific parameters to be distributed log-normally according to the population-based model fit in [ ]. Note that only the marginal distributions are given, so our computations are ignorant of any covariances between parameters. Also, it was observed that the parameter-dependent initial conditions can have negative components at certain points in the parameter space. Thus, when drawing parameters from the hypothesized distribution, we keep only parameter sets which give non-negative initial conditions.
. Identifiability
In this work, we use a sensitivity-based method for local identifiability analysis. Many similar approaches are reviewed in [ ]. To motivate this approach, consider as in [ ] the first order Taylor expansion
which approximates the change in model output given a small perturbation ∆q = q − q * to the parameters. Now suppose we have experimental observationsŷ (t k ). Substituting the Taylor approximation into the least squares cost function, we obtain
where the second step assumes the residuals r k (q * ) =ŷ − y(t k , q * ) are small and negligible. This approximation to the cost function can be expressed concisely as
where S is the so-called sensitivity matrix, which is defined by
Note that J(q * ) = , which is expected since we took the residuals r k (q * ) to be negligible. Now suppose ∆q is an eigenvector of S T S with S T S∆q = λ∆q. Then we have
We see that if ∆q is an eigenvector with eigenvalue λ = , then to second order approximation J(q * + h∆q) = .
The least squares cost function does not change values when moving from q * to q * + h∆q, with h arbitrary. Thus, the parameters are locally unidentifiable at q * . In practice, S T S having very small eigenvalues is also a problem for parameter identification. Thus, we have the following algorithm from Quaiser and Mönnigmann [ ]: ( ) Form the matrix F = S T S and compute eigenvalues:
( ) If |λ | is less than some threshold ε, conclude that there is an unidentifiable parameter. (Following [ ], we use ε = − , but in principle the choice of ε ought to depend on measurement error level.) ( ) The largest magnitude component of the eigenvector v corresponds to the least identifiable parameter.
Remove the corresponding column from S and repeat from step . An eigenvector v with small corresponding eigenvalue is a direction in the parameter space in which the cost function is locally flat. Intuitively, by removing the parameter associated with the largest component of v, i.e., the primary direction of the vector, we avoid this degeneracy.
Note that this algorithm is most appropriate when the parameters q are nondimensional or have comparable scales; otherwise, the directions of the eigenvectors of F are not meaningful. Moreover, recall that our optimization criterion involves the log viral load, or log(V I + V NI ) in the Snoeck model. For these reasons, we use the following scaled sensitivity matrix in our local identifiability analysis:
where y = V I + V NI is the total viral load as before.
. Subset selection
It is desirable that the parameters estimated from experimental data are both sensitive and identifiable. In this work, we use a simple algorithm to choose a subset of parameters with these properties: ( ) Begin with the full parameter set Q. ( ) Remove parameters found to be not sensitive during global analysis to obtain Q S ⊂ Q. ( ) Conduct local identifiability analysis on parameters in Q S to obtain an identifiable parameter set Q I .
Since the third step is local, we repeat the procedure at many points in the parameter space. Parameters which appear most often in Q I form the final subset. The parameters not in this final subset are fixed to the "typical values" shown in Table . Results
. Model analysis
Global sensitivity analysis was performed on the Snoeck model according to the Monte Carlo approximation detailed in Section . . A total of , parameter sets were split into two categories: one for parameter sets which produce uncensored viral load data and another for parameter sets which produce viral loads that fall below the censoring level. All simulations were conducted using weeks of treatment and weeks of observations at week intervals. The averaged sensitivity coe cients for the uncensored and censored cases are illustrated in Figures (a) and (b) , respectively, and % confidence intervals are included as error bars.
Sensitivities for the censored data are lower overall, which is expected since sensitivity at censored time points is considered zero. More importantly, note the sharp break in Figure ( a) between the six most sensitive parameters and the two least sensitive parameters. This pattern suggests that the insensitive parameters r and k should not be estimated. A similar pattern of sensitivities is observed in Figure (b) , although the relative sensitivity of ρ is not as clear. Conservatively, we elect not to estimate ρ.
The global sensitivity results were used to conduct subset selection using parameter sets split into the same two categories. Out of these parameter sets, yielded censored data and the remaining yielded uncensored data. Subset selection in the censored data case (Figure (b) ) is less conclusive. The final subset of parameters contains those which are identifiable at least % of the time:
This set is smaller than the one chosen for uncensored data, which is consistent with our expectations.
. Model fitting
After subset selection, the model was fit to two data sets taken from [ ]. The first set of data is from a patient exhibiting partial virologic response (PVR). The patient in the second data set undergoes a relapse after viral load dips below the censoring level. Since the data are censored, expectation maximization was used to obtain a maximum likelihood estimate of the parameters. The data and model fit are shown in Figure , and the optimized parameters are listed in Table . We reiterate that only the parameters chosen by the subset selection are estimated, and the rest are fixed to 'typical values' found in [ ]. Notice that the data shown in Figure ( a) comes from a patient undergoing weeks of treatment, while we performed subset selection under the assumption of a week treatment period. Di erent treatment times will a ect parameter sensitivities, which are the main factors in our subset selection method. In this case, however, subset selection with a week treatment period yielded the exact same results in the uncensored case, though the censored case was di erent.
A second, smaller data set exhibiting PVR with a week treatment period was also used; the fit is shown in Figure . While the model fit appears adequate, the fit value for the parameter δ was around . , which is two orders of magnitude larger than the typical value. Further inspection reveals that several parameter sets, many containing unrealistic estimates, can fit this data well. We will discuss this degenerate behavior in the next section. 
Parameter PVR fit ( weeks)
Relapse fit
Table .
Optimized parameters for the PVR ( weeks treatment) and Relapse data sets. Bold values are those chosen by subset selection and subsequently estimated. For the PVR data, % confidence intervals are included. 
Discussion
Our application of sensitivity and identifiability analysis to the Snoeck model yields several insights. Over the chosen parameter distribution, the drug decay constant k and regeneration rate constant r are much less sensitive than the other parameters. In the context of HCV treatment, this result suggests that liver regeneration may be less responsible for di erences in viral load between patients. Further study could focus specifically on whether the regeneration rate r is significantly associated with di erent patient outcomes. The parameter subsets chosen provided reasonably good fits to data in the first two cases we presented. Nevertheless, Figure (b) suggests that using three parameters may not be adequate. Future work should systematically evaluate the e ects of subset selection on parameter estimation. In particular, fixing parameters deemed locally unidentifiable may compromise the power of the model to fit certain data sets.
Due to the small number of observations, confidence intervals for the parameters in Table are all wide relative to the size of the estimated parameters. However, if we allow the parameter p to vary and repeat the estimation, the problem worsens. When p is estimated, the estimates themselves change little (less than %), but confidence intervals all become wider. Relative to the previous intervals, the width of the interval on δ becomes twice as large and that of c is inflated -fold. Based on the subset selection results one might have tried estimating both p and c, but examining the confidence intervals makes it clear that meaningful inference can only be made about one parameter.
One caveat of this methodology is that global identifiability issues may be missed. Fitting the model to the data set of Figure yielded many parameter sets with very similar squared errors. Table illustrates the closeness of fit between parameter sets far away from one another, which heuristically suggests global unidentifiability. Such behavior implies that the least squares fit is highly sensitive to the measurement error, which makes the parameters practically unidentifiable.
Parameter Fit
Fit Fit
Table .
Three parameter sets from fitting to the PVR data with weeks treatment. Unidentifiability is suggested by the closeness in the sum of squared errors (SSE) objective. Estimated parameters are in bold.
There has been some discussion in the literature regarding the value of the constant r. day − which was based on simulations for liver graft donors. Clearly there is a big di erence between these values. This discrepancy was discussed by Dahari, Lo, Ribeiro and Perelson in [ ]. They refitted the liver regeneration data and obtained values of r = . , .
day − . Clearly the second value has moved closer to the value used in [ ], but is still an order of magnitude larger. However, we have shown that r is the least sensitive of all the model parameters when fitting to censored data (Figure (b) ) and is also very insensitive when fitting to uncensored data (Figure (a) ). This shows that the value of r has little influence on the fitting process, which explains why similar models can both fit data with widely varying values of r. 
Model output in the original and modified Snoeck models is shown in Figure using the same parameter sets as the fits in Figure . In both cases the viral load drops slightly lower in the modified model. Otherwise, the results are almost identical. Similarly, the sensitivity functions evaluated using these two parameter sets were found to be only slightly di erent in the modified Snoeck model. We stress that our focus is on inverse problem methodologies more so than modeling issues, and at any rate our subset selection results would likely not be a ected by the additional term in the model.
Conclusions
This work illustrates the use of several techniques useful in inverse problems. We use global sensitivity analysis, a sensitivity-based identifiability analysis, and a simple algorithm to choose subsets of parameters to estimate. These techniques were applied to a recent model for intra-patient HCV dynamics, and we found that not all parameters estimated in the original study were sensitive and identifiable. Furthermore, we stress that methods presented would be useful for parameter estimation in a wide variety of dynamical models, especially those in the form of nonlinear ODEs. More widespread application of sensitivity and identifiability techniques in these models should lead to more accurate inferences about the model parameters and thus models which are more relevant to the clinical setting. Our results pertain to HCV patients undergoing a treatment of interferon-α (IFN) and ribavirin. Recently, a number of direct-acting antivirals (DAAs) have been developed which significantly improve patient outcomes [ , ] . The reader is referred to [ ] for a review of some recent models pertaining to treatment with DAAs. 
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